New diabetes drug ZT002 begins first human safety tests
Disease control
Completed
This early-phase trial tested the safety and tolerability of a new drug called ZT002 in 32 healthy volunteers. Participants received either a single or multiple doses of ZT002 or a placebo by injection. The study aims to see if the drug is safe enough to move into larger trials f…
Phase: PHASE1 • Sponsor: QL Biopharmaceutical Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC